A simple and elegant political solution for American Cannabis.
A simple and elegant political solution for American Cannabis.

There are 38 states and 4 U.S. territories with medical or hybrid adult use cannabis programs.

Schedule VI is a proposed new schedule designed to preserve their rights to control & regulate marijuana a.k.a. cannabis.

As of August 2023, The United States Department of Health & Human Services & the Drug Enforcement Administration are considering rescheduling marijuana outside of Schedule I.

We believe that regardless of the HHS and DEA re-scheduling process moving marijuana to Schedule III or lower, federal regulatory capture on the intrastate commerce of marijuana and marijuana products would break state and local ecosystems while handing the industry to mature apex industries.

State Ecosystem + Local Industry

Patient + Consumer

Controlled Substances Act: Schedules I - V

(1) SCHEDULE I.—
(A) The drug or other substance has a high potential for abuse.
(B) The drug or other substance has no currently accepted medical use in treatment in the United States.
(C) There is a lack of accepted safety for use of the drug or other substance under medical supervision.

(2) SCHEDULE II.— 
(A) The drug or other substance has a high potential for abuse. 
(B) The drug or other substance has a currently accepted medical use in treatment in the United States or a currently accepted medical use with severe restrictions.
(C) Abuse of the drug or other substances may lead to severe psychological or physical dependence.

(3) SCHEDULE III.— 
(A) The drug or other substance has a potential for abuse less than the drugs or other substances in schedules I and II.
(B) The drug or other substance has a currently accepted medical use in treatment in the United States.
(C) Abuse of the drug or other substance may lead to moderate or low physical dependence or high psychological dependence.

4) SCHEDULE IV.—
(A) The drug or other substance has a lowpotential for abuse relative to the drugs or other substances in schedule III.
(B) The drug or other substance has a currently accepted medical use in treatment in the United States.
(C) Abuse of the drug or other substance may lead to limited physical dependence or psychological dependence relative to the drugs or other substances in schedule III.

5) SCHEDULE V.—
(A) The drug or other substance has a low potential for abuse relative to the drugs or other substances in schedule IV.
(B) The drug or other substance has a currently accepted medical use in treatment in the United States.
(C) Abuse of the drug or other substance may lead to limited physical dependence or psychological dependence relative to the drugs or other substances in schedule IV.

Schedule VI (6) is a small update to the Controlled Substances Act that includes Safe banking, Fair Taxation, Consumer Protection and Health

DRAFT TEXT: PROPOSED Schedule VI Language

(6) Schedule VI.-

(A) The drug or other substance is listed in Schedule I.

(B) The drug or other substance is subject to some degree of abuse and has a currently accepted medical use in treatment or is restricted for Sale to Adults over the age of 21 in the States of Alabama, Alaska, Arizona, Arkansas, California, Colorado, Connecticut, Delaware, Florida, Georgia, Hawaii, Illinois, Iowa, Kentucky, Louisiana, Maine, Maryland, Massachusetts, Michigan, Minnesota, Mississippi, Missouri, Montana, Nevada, New Hampshire, New Jersey, New Mexico, New York, North Dakota, Ohio, Oklahoma, Oregon, Pennsylvania, Rhode Island, Utah, Vermont, Virginia, Washington, West Virginia, the District of Columbia, the Commonwealth of the Northern Mariana Islands, the United States Virgin Islands, Guam, or Puerto Rico.

(C) Drugs grown or manufactured for intrastate Commerce shall be regulated exclusively by the States. All United States Codes, Internal Revenue Codes and any federal agency rules shall be applied exclusively using this schedule for licensed producers of the drug in the States and Territories listed in (B). Licensed producers shall be defined according to the statutes or codes of the States and Territories listed in (B).

(D) Drug regulation and restriction is governed by each State or Territory listed individually in (B). If a State or Territory not listed in (B) legalizes the drug or other substance for medical use in treatment or makes it available for Sale only to adults over the age of 21, the agency regulating the drug in that State or Territory can notify the Attorney General that it is to be added to (B). The Attorney General shall add the State or Territory to (B) within ninety days of notification.

We are accepting membership applications for licensed U.S. cannabis operators, cannabis state associations, educational & research institutions, related ancillary businesses, and cannabis investors.

The Cannabis industry & advocacy groups are often denied First Amendment rights on social media. In light of Elon Musk's takeover of Twitter, we have created an official account.​

Ⓒ  2023 Schedule 6 Foundation